Marketing-authorisation holder
Biolitec Pharma Limited
8 medicines in 4 countries, as authorisation holder.
Group structure
Part of
BiolitecPharmaceutical groupOther companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Eyluxvi 40 mg/ml oplossing voor injectie in een injectieflaconOplossing voor injectie | Aflibercept | Netherlands | Authorised | 2025 |
| FOSCANSoluzione iniettabile | Temoporfin | Italy | Authorised | |
| Foscan | Temoporfin | EU (EMA) | Authorised | 2001 |
| Foscan 1 mg/ml, oplossing voor injectieOplossing voor injectie | Temoporfin | Netherlands | Authorised | 2007 |
| FOSCAN 1 mg/ml SOLUCION INYECTABLE1 mg · Solución inyectable | Temoporfin | Spain | Authorised | 2011 |
| FOSCAN 1 mg/ml SOLUCION INYECTABLE1 mg · Solución inyectable | Temoporfin | Spain | Authorised | 2011 |
| FOSCAN 1 mg/ml SOLUCION INYECTABLE1 mg · Solución inyectable | Temoporfin | Spain | Authorised | 2011 |
| FOSCAN 4 mg/ml SOLUCION INYECTABLE1 mg · Solución inyectable | Temoporfin | Spain | Authorised | 2011 |